Entrada Therapeutics
TRDA
#9077
Rank
S$0.21 B
Marketcap
S$5.61
Share price
-6.25%
Change (1 day)
-57.50%
Change (1 year)

EPS for Entrada Therapeutics (TRDA)

EPS in 2026 (TTM): S-$4.94

According to Entrada Therapeutics's latest financial reports the company's current EPS (TTM) is S-$4.95. In 2025 the company made an earnings per share (EPS) of S-$4.46 a decrease over its 2024 EPS that were of S$2.57.

EPS history for Entrada Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$4.9410.57%
2025S-$4.46-273.87%
2024S$2.57
2022S-$3.9031.74%
2021S-$2.96